EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, European Medical Solutions's Enterprise Value is €34.43 Mil.
European Medical Solutions's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €2.49 Mil. Therefore, European Medical Solutions's EV-to-FCF for today is 13.80.
The historical rank and industry rank for European Medical Solutions's EV-to-FCF or its related term are showing as below:
STU:AS00'
s EV-to-FCF Range Over the Past 10 Years
Min: -628.72 Med: -5.12 Max: 14.55
Current: 13.67
During the past 13 years, the highest EV-to-FCF of European Medical Solutions was 14.55. The lowest was -628.72. And the median was -5.12.
STU:AS00's EV-to-FCF is ranked better than 53.47% of 331
companies
in the Biotechnology industry
Industry Median: 15.9
vs STU:AS00: 13.67
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
European Medical Solutions (STU:AS00) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
European Medical Solutions's PE Ratio (TTM) for today is calculated as:
European Medical Solutions's share price for today is €4.80.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. European Medical Solutions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.435.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
European Medical Solutions EV-to-FCF Related Terms
European Medical Solutions EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:AS00 vs VRTX, REGN, ALNY: EV-to-FCF Comparison
For the Biotechnology subindustry, European Medical Solutions's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
European Medical Solutions EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, European Medical Solutions's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where European Medical Solutions's EV-to-FCF falls into.
European Medical Solutions's current Enterprise Value is €34.43 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. European Medical Solutions's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €2.49 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
European Medical Solutions (STU:AS00) has a EV-to-FCF of 13.80 as of Jul. 01, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on European Medical Solutions and its competitors. According to the industry distribution chart, European Medical Solutions ranks #154 out of 331 companies in the Biotechnology industry, placing it in the top 46.5%.
Is European Medical Solutions' EV-to-FCF too high?
European Medical Solutions' current EV-to-FCF is 13.80. The Biotechnology industry median EV-to-FCF is 15.90. European Medical Solutions' value of 13.80 is 13.2% below this industry median. Based on the distribution chart, European Medical Solutions ranks #154 out of 331 companies in the Biotechnology industry, which is above the industry midpoint. Overall, European Medical Solutions has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does European Medical Solutions' EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, European Medical Solutions ranks #154 out of 331 companies for EV-to-FCF. This puts European Medical Solutions in the upper half of its industry. The industry median EV-to-FCF is 15.90. European Medical Solutions' value of 13.80 is 13.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 15.90, based on 331 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. European Medical Solutions's current EV-to-FCF of 13.80 is 13.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on European Medical Solutions and its competitors. For the Biotechnology industry, the median EV-to-FCF is 15.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. European Medical Solutions's current EV-to-FCF is 13.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is European Medical Solutions stock overvalued right now?
European Medical Solutions (STU:AS00) has a current EV-to-FCF of 13.80. The stock's GF Value™ is €8.11, compared to a current price of €4.80 — trading 40.8% below its estimated fair value. The current EV-to-FCF is 13.80 and 13.2% below the Biotechnology industry median of 15.90. European Medical Solutions' overall GF Score™ is 50/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For European Medical Solutions (STU:AS00), the current EV-to-FCF is 13.80 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is European Medical Solutions (STU:AS00) Overvalued in 2026?
Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued.
The current stock price of €4.80 is trading 40.8% below its estimated GF Value™ of €8.11.
Key valuation signals for STU:AS00:
EV-to-FCF: 13.80
GF Value™: €8.11 vs. price of €4.80 (40.8% below fair value)
Industry Position: 13.2% below the Biotechnology median (#154 of 331)
No single metric tells the full story. See the STU:AS00 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
50GF Score
Get the complete analysis for STU:AS00
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:AS00 has been successfully added to your 
